A 39-year-old woman was admitted to the Department of Pulmonary and Critical Care Medicine for fever, cough, and dyspnea. Her medical history was unremarkable. In the 2 weeks prior to her admission, she had fever at 40°C, sore throat, arthralgias involving the hands and knees, and transient skin rash. She was treated with amoxicillin–clavulanic acid, without any improvement, and was finally hospitalized with pulmonary symptoms. She was rapidly transferred to the intensive care unit (ICU), with tachypnea (respiration=30 breaths/min) and severe hypoxemia (p
aO2=46 mmHg, p
aCO2=39 mmHg, and arterial oxygen saturation=76%). Chest x-ray demonstrated diffuse interstitial opacities with mild pleural effusion. Biologic tests revealed leukocytosis (white blood cells=22,000 mm−3), with polymorphonuclear neutrophils=90%, hemoglobin=8.4 g/l, and platelets=571,000 mm−3. C-reactive protein (CRP) count was 290 mg/l (normal range, <5 mg/l), with hepatic cytolysis and cholestasis. Diagnosis of community-acquired pneumonia was suggested, and antibiotic therapy with ceftriaxone and spiramycin was introduced, without any improvement, after 5 days. Chest CT scan at this time showed parenchymal alveolar densities mainly involving the lower lobes, together with moderate pleural effusion. Abdominal and pelvic CT scans yielded normal results. Bronchoalveolar lavage (BAL) showed normocellular content with 30% neutrophils, and cultures yielded negative results. Echocardiography revealed a diagnosis of moderate pericardial effusion. All other microbiological investigations (including blood, urine, and cerebrospinal cultures; and serological tests for Mycoplasma pneumoniae, Chlamydia pneumoniae, legionellosis, Q fever, HIV, Cytomegalovirus, hepatitis B virus, and hepatitis C virus) yielded negative results. Moreover, antinuclear antibodies, rheumatoid factor, anti-DNA, and anti-neutrophilic cytoplasmic antibodies (ANCAs) were absent. There was no proteinuria, and bone marrow analysis yielded negative results. Ferritinemia was 8,590 μg/l (normal range, 20–300 μg/l) and glycosylated ferritinemia 11% (normal range, 50–80% of total ferritin). A diagnosis of AOSD was suggested, and 1 g of methyl prednisolone pulse i.v. for 3 days was administered, followed by prednisone at 1 mg/kg body weight per day. Her clinical symptoms and chest x-ray results improved dramatically within 2 days. Fever, skin rash, and arthralgias relapsed at 6 months with steroids reduction, but without pulmonary symptoms.